EXOZ · eXoZymes Inc
United States · RS rating 6 · As of 2026-10-14
| Price | 4.60 USD |
|---|---|
| 1-day change | +0.2% |
| RS rating (overall / 1M / 3M / 12M) | 6 / 6 / 14 / 10 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 1 / 9 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -17.9% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +72.1% |
| Market cap (USD) | $87.3M |